Navigation Links
Banning the drug Valdecoxib In India

The National Pharmaco Vigilance Advisory Committee has prohibited the sale and manufacture of the drug// Valdecoxib, indicated for arthritis and acute pain in India under the Drugs and Cosmetics Act.

Studies done abroad have indicated that the drug Valdecoxib is found to double the risk of heart attacks and strokes and also result in severe skin reactions.

Although some of the leading pharmaceutical companies have stopped manufacturing it and have withdrawn the drug from the Indian market, a few leading companies differ in opinion and have adopted a “wait and watch” approach as a result of which they have still not withdrawn the drug from the market.

Some of the leading drugs manufacturing companies in India also have a major market-share in the product, with sales amounting to Rs.25 crore another reason for their reluctance to withdraw the drug from the market.

According to US officials, the request for withdrawal of the drug was made by the FDA after seeking approval from a committee they had constituted for advice on the issue. Higher authorities in the Indian Drug Manufacturers Association however feel that based on US models, the drug should not be banned in India as each countries requirement are different and withdrawal and approval of drugs should be made accordingly.

'"/>




Page: 1

Related medicine news :

1. Banning Smoking in the Home Helps Infants
2. Doctors Ask MPs To Protect Human Rights By Banning Smoking In Enclosed Public Spaces
3. Punjab Plans of Banning Sex Determination Kit from US
4. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
5. Is Diabetes the Leading Cause of Kidney Failure in India
6. AIDS Disaster in India is Imminent
7. Indian Prime Minister has successful Knee Replacement Surgery
8. International community warns India on HIV situation
9. India takes on foot-and-mouth disease by vaccinating animals
10. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
11. India to benefit from pharma companies move
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics ... PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... of Morris F. Collen, a pioneer in the field of medical informatics, this prestigious ...
(Date:10/12/2017)... ... 2017 , ... Leading pediatric oncology experts at Children’s National Health System ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical Officer ... physician colleagues, skilled nursing facility medical directors and other clinicians at various events ... Care." , "At many of these conferences we get to educate other physicians, ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , the ... chains, has published the first annual edition of its Global CSR Risk ... 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly ... ... Performance Index ...
(Date:9/12/2017)... Sept. 12, 2017  ValGenesis Inc., the global ... is pleased to announce the appointment of Dr. ... its Board of Directors and Chairman of Advisory ... life science companies to manage their entire validation ... paper in this process. Furthermore, ValGenesis VLMS enables ...
Breaking Medicine Technology: